Loading
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 02 Oct 2026 for Tectonic Therapeutic, Inc., €32k.
Filing timeline
BuySaleAlise Reicin
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
Closed purchases
Market purchases
2
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +33.8%Entry US$22.28 · Close at T+90 US$29.80
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Alise Reicin: trading record in brief
Alise Reicin, listed as chief executive, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Tectonic Therapeutic, Inc. and Celgene Corp /DE/. The record holds 17 filings, for trades running from 1 November 2019 to 25 September 2026.
No open-market sale appears; the market trades are 2 purchases worth €89k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 12 share grants and 2 option exercises. Since January 2026: 2 purchases and no sales on the market.
The latest filing, published on 2 October 2026, reports a share grant of €32k in Tectonic Therapeutic, Inc. The clock since the last published purchase (5 March 2026) now reads 233 days. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Alise Reicin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations16 total
1,545 shares@ US$23.670.0079% mcap16.6% of flowCommon StockSEC:0001757533-26-000016:0
76,500 shares0Common StockSEC:0001757533-26-000009:0
2,500 shares@ US$21.1027.4% of flowCommon StockSEC:0001757533-26-000005:0
Canonical exit: 12 May 2026 (T+90)
4,104 shares@ US$23.2249.8% of flowCommon StockSEC:0001757533-26-000004:0
10,966 shares@ US$2.3813.7% of flowCommon StockSEC:0001757533-26-000002:0
14,700 shares0Common StockSEC:0001757533-25-000004:0
859 shares@ US$19.819.1% of flowCommon StockSEC:0001415889-25-018106:0
36,047 shares0Common StockSEC:0001415889-25-003225:0
11,717 shares0Common StockSEC:0001415889-24-028516:0
166,580 sharesCommon StockSEC:0001415889-24-017952:0
4,298 shares0Common StockSEC:0001415889-19-001372:0
8,927 shares0Common StockSEC:0001415889-19-001372:1
24,209 shares0Common StockSEC:0001415889-19-001372:2
44,615 shares0Common StockSEC:0001415889-19-001372:3
11,903 shares0Common StockSEC:0001415889-19-001258:0
4,722 shares@ US$108.53100.0% of flowCommon StockSEC:0001415889-19-001258:1
16 of 16 declarations
